Dianthus Therapeutics (DNTH) Q3 2026 Earnings

4AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-1.07
-1
-0.92
-0.85

Details

Expected EPS
-0.846284
Actual EPS
-0.9
Surprise EPS
-0.05
Surprise Percent
+6.35%

Description

Dianthus Therapeutics (DNTH) has reported earnings of -0.9 per share for Q3 2026.

0 Comments

Share your thoughts